Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies
Title:
Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies
Author:
Marotta, P. Bailey, R. Elkashab, M. Farley, J. Feinman, S. V. Peltekian, K. Poliquin, M. Witt-Sullivan, H. Rampakakis, E. Drolet, M. Cooper, C.
Appeared in:
European journal of clinical microbiology & infectious diseases